Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum (Q40116758)

17 September 2017

Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum (English)

1 reference

17 September 2017

0 references

0 references

1

Robert Bucki

1 reference

17 September 2017

Audra Goach Sostarecz

2

1 reference

17 September 2017

Fitzroy J Byfield

3

1 reference

17 September 2017

Paul B Savage

4

1 reference

17 September 2017

Paul A Janmey

5

1 reference

17 September 2017

language of work or name

English

0 references

publication date

21 June 2007

1 reference

Journal of Antimicrobial Chemotherapy

17 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 September 2017

60

1 reference

17 September 2017

3

1 reference

17 September 2017

535-545

1 reference

Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa

17 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Inflammation and infection in naive human cystic fibrosis airway grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Activity of abundant antimicrobials of the human airway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Engineering actin-resistant human DNase I for treatment of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Antimicrobial peptide therapeutics for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Reduction in the bactericidal activity of selected cathelicidin peptides by bovine calf serum or exogenous endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Impact of LL-37 on anti-infective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Antibacterial properties of cationic steroid antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Structure and biology of cathelicidins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Peptide antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Antibacterial peptides: basic facts and emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Antibacterial and antimembrane activities of cecropin A in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Inactivation of endotoxin by human plasma gelsolin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

AFM imaging of bacteria in liquid media immobilized on gelatin coated mica surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Structural investigations of DNA-polycation complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Macromolecular mechanisms of sputum inhibition of tobramycin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Interaction between heat shock proteins and antimicrobial peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Structure and function of lipopolysaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKM218

21 January 2018

Identifiers

DOI

10.1093/JAC/DKM218

1 reference

17 September 2017

1 reference